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Abstract
CD200 receptor (CD200R) negatively regulates peripheral and mucosal innate immune
responses. Viruses, including herpesviruses, have acquired functional CD200 orthologs,
implying that viral exploitation of this pathway is evolutionary advantageous. However, the
role that CD200R signaling plays during herpesvirus infection in vivo requires clarification.
Utilizing the murine cytomegalovirus (MCMV) model, we demonstrate that CD200R facili-
tates virus persistence within mucosal tissue. Specifically, MCMV infection of CD200R-
deficient mice (CD200R-/-) elicited heightened mucosal virus-specific CD4 T cell responses
that restricted virus persistence in the salivary glands. CD200R did not directly inhibit lympho-
cyte effector function. Instead, CD200R-/- mice exhibited enhanced APC accumulation that in
the mucosa was a consequence of elevated cellular proliferation. Although MCMV does not
encode an obvious CD200 homolog, productive replication in macrophages induced expres-
sion of cellular CD200. CD200 from hematopoietic and non-hematopoietic cells contributed
independently to suppression of antiviral control in vivo. These results highlight the CD200-
CD200R pathway as an important regulator of antiviral immunity during cytomegalovirus in-
fection that is exploited by MCMV to establish chronicity within mucosal tissue.
Author Summary
Immune inhibitory receptors, including CD200 receptor (CD200R), can limit immune re-
sponses in the mucosa to restrict reactivity to the plethora of harmless antigens that
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mucosal surfaces are continually exposed to. However, viruses may exploit these suppres-
sive mechanisms to enable their persistence and spread. Many viruses, including herpesvi-
ruses, have acquired functional homologs of CD200, the ligand of CD200R, implying that
viral exploitation of this pathway is evolutionary advantageous. We now show that the β-
herpesvirus murine cytomegalovirus (MCMV) takes advantage of the CD200R inhibitory
pathway to persist within a mucosal site of MCMV persistence, the salivary glands. Mice
deficient in CD200R mounted elevated antiviral immune responses that were driven by
the increased division and accumulation of myeloid cells that function to orchestrate the
generation of antiviral effector immune responses. Interestingly, MCMV infection of mye-
loid cells up-regulated CD200 expression. Thus, MCMV exploits the CD200 pathway to
persist within mucosal tissue.
Introduction
CD200R is an Immunoglobulin superfamily family member that is expressed by hematopoietic
cells, with notably high expression on myeloid cells [1]. The ligand of CD200R, CD200 (OX2),
is broadly expressed by cells of hematopoietic and non-hematopoietic origins [2]. The primary
function of the CD200R pathway is to limit immune reactivity. CD200-CD200R interactions
induce a unidirectional inhibitory signal within CD200R-bearing cells that is mediated by tyro-
sine motifs in the cytoplasmic domain of CD200R that recruit DOK2 and RasGAP, resulting in
inhibition of the ERK pathway [3–6].
The CD200R pathway negatively regulates myeloid cell homeostasis in the periphery [7],
and in the pulmonary [8] and, to a lesser extent, the intestinal [9] mucosa. CD200R signaling
limits the rapid onset of experimental autoimmune encephalomyelitis [3, 7] and restrains
bacterial-induced inflammation [10]. Importantly, CD200R also restricts viral-induced inflam-
mation during respiratory influenza infection [9, 11] and herpes simplex virus (HSV) infection
of the cornea [11]. However, CD200R also restricts IFN-dependent control of corona virus
infection via regulation of TLR7 [12] and control of intracranial HSV infection [13], demon-
strating that this inhibitory receptor can impinge on protective antiviral immunity.
During evolution, numerous herpesviruses have acquired proteins with the potential to in-
duce immune inhibitory receptor signaling [14]. For example, human cytomegalovirus
(HCMV) encodes a functional homolog of the inhibitory cytokine interleukin-10 (IL-10) [15].
Rhesus CMV lacking its IL-10 homolog induces increased virus-specific immune responses
[16], and IL-10R signaling during murine cytomegalovirus (MCMV) infection antagonizes an-
tiviral immunity and facilitates virus persistence [17–19]. Thus, these studies provide in vivo
experimental evidence supporting a rationale for CMV exploitation of host immune
regulatory pathways.
Intriguingly HCMV UL119–121 proteins display homology to human CD200 [20], al-
though it is currently unknown whether they induce inhibitory signaling through CD200R.
However, numerous herpesviruses are known to encode functional CD200 orthologs
(vCD200s) implying that exploitation of this inhibitory pathway is potentially advantageous
for herpesviruses. The most well-characterized vCD200 is the Kaposi’s sarcoma-associated her-
pesvirus (KSHV) protein K14, which suppresses the activation of neutrophils [21], basophils
and NK cells [22], T cells [23] and macrophages [24] in vitro. Furthermore, the English isolate
of rat cytomegalovirus (RCMV-E) encodes a CD200 homolog (e127) capable of binding
CD200R [25, 26].
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Despite the possible importance of the CD200-CD200R pathway in modulating anti-CMV
immunity, how it influences antiviral immune responses and virus replication during infection
in vivo requires clarification. To investigate this, we studied MCMV infection in wild type mice
and mice lacking CD200R. Experiments revealed a pivotal role for CD200R regulation of mye-
loid cell responses in limiting antiviral CD4 T cell responses. We provide evidence that MCMV
exploits the CD200-CD200R pathway to facilitate persistent infection within mucosal tissue.
Results
CD200R promotes MCMV persistence in the salivary glands
MCMV replicates in numerous organs, including the spleen, liver and lungs, during acute in-
fection, prior to dissemination to the salivary glands (SGs), in which MCMV replicates for 1–2
months [27, 28]. We hypothesized that CD200R signaling may facilitate MCMV replication in
vivo. To test this, wild type C57BL/6 (wt) and CD200R-/- mice were infected with MCMV and
virus load measured. Peak acute MCMV replication at day 4 post-infection (pi) in the spleen
(Fig. 1A) and liver (Fig. 1B) was unaltered by CD200R deficiency. However, CD200R-/- mice
exhibited a reduced burden of replicating virus (Fig. 1A) in the spleen 7 days pi.
We next investigated whether CD200R promoted MCMV persistence. In our model, repli-
cating virus is first detectable in the SGs at day 7 pi. Virus load in wt and CD200R-/- mice day
7 pi was comparable (Fig. 1C), suggesting that improved antiviral control in spleens of
CD200R-/- mice (Fig. 1A) did not influence dissemination to the SGs and associated brown fat
in which MCMV replicates at this time-point [29]. Crucially, however, CD200R-/- mice re-
stricted persistent MCMV replication in the SGs 14 days pi, and more CD200R-/- mice cleared
MCMV by day 33 pi as compared to wt controls (Fig. 1C). Thus, intact CD200R during chronic
infection promoted virus persistence within this mucosal organ.
CD200 and CD200R are expressed during MCMV infection
Consistent with biological impact of CD200R within the SGs, we observed significant CD200R
expression by CD11c+MHC II+ salivary gland (SG) APCs (referred to hereafter as SG-APCs,
Fig. 1D&E), which are phenotypically indicative of tissue-resident macrophages [30], and NK
cells (Fig. 1D) but not CD4 and CD8 T cells (Fig. 1D). CD200R expression by SG myeloid cells
was notably higher than splenic counterparts (Fig. 1E), demonstrating enhanced expression of
CD200R in mucosal versus non-mucosal sites of MCMV infection. CD200R expression by my-
eloid cells in both compartments was relatively stable during infection, with a slight reduction
in the intensity of CD200R expression 4 days pi prior to recovery to steady-state levels by
14 days (Fig. 1E). Interleukin-10 (IL-10) is expressed in the SGs in response to MCMV infec-
tion and promotes virus persistence [18, 31]. Although IL-10 induces CD200R expression by
macrophages in vitro [8], MCMV-infected IL-10-/- mice exhibited no alterations in CD200R
expression by myeloid cells during infection (Fig. 1F). Thus, CD200R was expressed during
infection but was not significantly upregulated in response to MCMV, by either an IL-10-
dependent or independent mechanism.
Unlike certain herpesviruses [14, 24], MCMV does not encode an obvious vCD200 [32].
Within infected SGs, CD200+ cells were predominantly large CD31+ cells (Fig. 2A, isotype con-
trols:S1A Fig.) that were EpCAM- (Fig. 2B), suggestive of endothelial cell origin, and not
EpCAM+ acinar epithelial cells in which MCMV replicates during the persistent phase of infec-
tion [33]. CD200+ cells did not express alpha smooth muscle actin (S1B Fig.), also demonstrat-
ing these cells were not myoepithelial cells. Interestingly, CD200+ cells were often observed in
ring-like structures around acinar epithelial cells (Fig. 2B), indicative of capillary networks that
surround acini [34]. CD200+CD31+ cells were detectable in naïve SGs (S1C Fig.), and we
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observed no notable increase in the intensity of CD200 expression by CD31+ cells within in-
fected tissue. In addition to abundant CD200+CD31+ cells, a more scarce population of
CD200+CD45+ cells was also detectable within the SGs indicating the presence of CD200 on a
hematopoietic cell type(s) (Fig. 2C). Analysis by flow cytometry revealed significant CD200 ex-
pression by APCs and T cells within the SGs and spleen (Fig. 2D&E) during MCMV infection.
Figure 1. CD200R promotes MCMV persistence in the mucosa. (A-C) MCMV titres in the spleen (A), liver
(B) and SGs (C) were measured 4 and 7 (A&B) or 7, 14 and 33 (C) days pi. Individual mice and median are
shown. Horizontal dashed lines depict the lower limit of detection. (D) Histogram overlays of CD200R
expression by SG leukocytes at day 7 pi. Blue line = wt, shaded = CD200R-/-. (E&F) Intensity of surface
CD200R expression by APCs (E) isolated from the SGs and spleens of wt mice is represented as median
fluorescent intensity (MFI). Results represent the mean +/- SEM of 3 mice. (F) Wt and IL-10-/- mice were
infected with MCMV and on 7 or 14 days pi CD200R expression by SG-APCs was analyzed by flow
cytometry. Fluorescence Minus One (FMO) control = SG-APCs from infected wt mice 7 (left) or 14 (right)
days pi. Plots are representative of 3–4 mice. All data is representative of 2–3 separate experiments.
doi:10.1371/journal.ppat.1004641.g001
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Figure 2. CD200 is expressed during in vivoMCMV infection. (A-B) Wt mice were infected with MCMV
and SGs harvested 7 days pi. (A) CD31 (green) and CD200 (red) co-localization in SGs. (B) Distinct CD200
(red) expression from EpCAM+ (green) acinar epithelial cells (top). Isotype controls for CD200 (Rat IgG2a-
Biotin) and EpCAM (Rabbit IgG), and the secondary antibodies Streptavidin 555 and Alexa Fluor 488 anti-
rabbit IgG (Bottom). (C) Hematopoietic cell (green [CD45]) expression of CD200 (red). (A-C) Magnification =
63x, white scale bars = 20μm. (D) Representative histogram overlays of CD200 expression by SG-APCs,
CD4 and CD8 T cells and NK cells in the SGs at day 7 pi. FMO controls are shown from cells isolated at day 7
pi. (E) CD200 expression by SG and splenic myeloid cell populations was assessed over time. Splenic DCs:
CD11c+MHC II+; splenic macs: F4/80+CD11b+. Data is represented as mean ± SEM of 3 mice/group
representing 4 experiments.
doi:10.1371/journal.ppat.1004641.g002
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MCMV infection of macrophages up-regulates CD200
Interestingly, we noted that CD200 expression by APC populations in the SGs and spleen was
induced above baseline upon infection (Fig. 2D&E). We hypothesized that MCMV infection of
myeloid cells may directly influence CD200 expression. We infected myeloid cell populations
in vitro using a multiplicity of infection of 1 that leads to an infection efficiency of less than
60% (see Fig. 3A for example), enabling us to compare surface CD200 protein levels on unin-
fected and infected cells from the same well of a tissue culture plate, as identified by flow cyto-
metric detection of the intracellular MCMVm06 protein. Infection of bone marrow-derived
macrophages (BM-DM, Fig.3A–C) and splenic macrophages (Fig.3B) up-regulated CD200
(Fig.3A–C). Importantly, we observed a marked increase in CD200 expression by infected
(m06+) as compared with uninfected (m06-) macrophages derived from the same wells
(Fig. 3A–C), suggesting that CD200 is preferentially up-regulated by macrophages in which
MCMV is actively replicating.
Infection of BM-DM with influenza did not trigger CD200 expression (Fig. 3D), demon-
strating that CD200 up-regulation is not a generic macrophage response to viruses. However,
CD200 expression is induced by ligation of TLRs, including TLR3 and TLR9 [10]; both of
which are triggered by MCMV [35, 36]. In accordance, TLR3 ligation by PolyI:C induced sub-
stantial CD200 mRNA expression by macrophages in an IFNβ-dependent manner (Fig. 3E).
To investigate whether MCMV induction of Cd200 transcription required productive replica-
tion, we compared expression following macrophage infection with IE3 knockout replication-
deficient MCMV (ΔIE3)[37] and replication-sufficient wt MCMV (pSM3fr). Macrophage ex-
posure to ΔIE3 MCMV induced a small, transient induction of CD200 mRNA in an IFNβ-
dependent manner (Fig. 3F), consistent with TLR-mediated induction of CD200 triggered dur-
ing incomplete MCMV replication, and the moderate CD200 protein expression by uninfected
(m06-) macrophages derived from infected cell cultures (Fig. 3C). In contrast, replicating
MCMV induced substantial and prolonged CD200 mRNA expression independently of IFNβ
(Fig. 3G). Furthermore, inhibition of viral DNA polymerase with phosphonoacetic acid (PAA)
antagonized MCMV-induced CD200 expression in BM-DMs (Fig. 3H), again demonstrating
the requirement for productive virus replication in this process. Importantly, we observed that
SG-APCs did not support MCMV replication in vitro in accordance with the absence of
detectable infection in vivo [38], and MCMV infection of splenic DCs did not further induce
CD200 expression (Fig. 3B). Thus, these data suggested that myeloid cells up-regulated CD200
during MCMV infection and, in the case of macrophages in secondary lymphoid tissues,
MCMV induces CD200 expression independently of TLR stimulation during productive
replication.
CD200 derived from hematopoietic and non-hematopoietic cells
promotes MCMV persistence
Given that CD200 expression by both hematopoietic and non-hematopoietic cells was ob-
served in MCMV-infected mice, we sought to understand which cellular compartment was re-
sponsible for inhibiting antiviral immunity. We made bone marrow chimeras derived from wt
mice or mice deficient of CD200, generating mice lacking CD200 within the hematopoietic
and/or radiation-resistant (non-hematopoietic) compartment. We then studied virus load in
SGs 14 days post-MCMV infection. Interestingly, deleting CD200 from either compartment re-
duced virus load as compared to wt>wt mice (Fig. 4), demonstrating that CD200 expressed by
hematopoietic and non-hematopoietic cells both delivered immune suppressive signals that
promoted MCMV persistence.
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Figure 3. MCMV induces CD200 expression bymacrophages. (A-C) Bone marrow-derived macrophages
(BM-DMs) were infected with pSM3fr MCMV and CD200 expression was assessed. (A) Representative
bivariant flow cytometry plots of MCMV infection (m06+) versus CD200 (top) and CD80 (bottom) 24 hrs pi.
(B) Representative histograms of CD200 expression by infected (m06+, blue) and uninfected/virus exposed
cells from the same well (m06-, red). BM-DMs (top), splenic F4/80+ macrophages (middle) and splenic
CD200R Restricts Myeloid Cell Orchestration of Anti-CMV Immunity
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CD200R restricts myeloid cell accumulation and proliferation
We assessed the impact of CD200R deficiency on virus-induced myeloid cell responses. Re-
duced MCMV persistence in CD200R-/- mice was accompanied by accumulation of splenic
DCs 14 days pi (Fig. 5A). The inability of SG-APCs to cross-present antigen to CD8 T cells (in
combination with MCMV down-regulation of MHC class I) has been shown to be responsible
for the lack of CD8 T cell-mediated control of MCMV replication in the SGs, demonstrating
that local antigen-presenting function of SG-APCs is a critical determinant of protective T cell
immunity during MCMV persistence [38]. Interestingly, SG-APC accumulation in infected
CD200R-/- mice was substantially increased 14 days pi (Fig. 5B&C). However, SG-APC num-
bers were comparable in wt and CD200R-/- mice following resolution of MCMV infection in
CD11chi MHC IIhi DCs (bottom). FMOs are cells from infected cell cultures (containing infected and
uninfected cells). (C) CD200 expression by MCMV-infected (m06+), MCMV-exposed (m06-) and ΔIE3
MCMV-infected BM-DMs was compared to expression by mock-infected cells. Data are expressed as
median fluorescence intensity (MFI) and are expressed as mean + SEM of 2 replicates. Results represent
2–5 experiments. (D) BM-DMs were infected or not with influenza strain PR8 (MOI:1), and CD200 expression
was assessed 24hrs later by flow cytometry. FMOs are from uninfected macrophages. Data from 1 of 2
experiments is shown. (E-G) BM-DMs were treated with (E) PolyI:C or infected with (F) replication deficient
ΔIE3 MCMV or (G) wt MCMV (pSM3fr) and cd200 expression assessed by microarray. (H) BM-DMs were
infected with wt MCMV +/- PAA, and CD200 expression was assessed 24hrs later. Data is shown as a
representative histogram (of 2 separate experiments) depicting CD200 expression by uninfected/virus
exposed cells (m06-, red), infected cells (m06+, blue) and PAA-treated m06+ cells (orange). Grey = m06+
untreated cells stained with isotype control (rat IgG2a-PE).
doi:10.1371/journal.ppat.1004641.g003
Figure 4. CD200 expressed by hematopoietic and non-hematopoietic cells facilitate MCMV
persistence.Mixed wt/CD200-/- bone marrow chimeras were generated and infected with MCMV. 14 days
later, replicating virus load in the SGs was assessed by plaque assay. Individual mice and median are shown.
Horizontal dashed line depicts the lower limit of detection. Data from 3 merged experiments is shown. Similar
results were observed in a fourth experiments but data was omitted due to inter-experimental variation—
median values for all groups were ~1 log lower than medians of data depicted in the Figure.
doi:10.1371/journal.ppat.1004641.g004
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Figure 5. CD200R restricts myeloid cell accumulation and SG-APC proliferation. (A) Time-course of accumulation of splenic CD11c+MHC II+ cells in wt
and CD200R-/- mice. Mean + SEM of 4–11 mice/group is shown. (B) Representative flow cytometry plots of CD11c+MHC II+ SG-APCs in wt (left) and
CD200R-/- (right) at day 7 pi. (C) Numbers of SG-APCs over time. Mean + SEM of 6 mice/group is shown. (D) Proliferating (EDU+) SG-APCs were assessed
by flow cytometry. Mean + SEM of 3–6 mice/group is shown. (E) Representative bivariant flow cytometry plots of EDU incorporation by SG-APCs in wt (left)
or CD200R-/- (right) mice at day 7 pi. Data is gated on live CD11c+MHC II+ cells. All results represent at least 2 independent experiments. (F&G) Wt mice
were infected with MCMV and SGs harvested 7 days pi. (F) MHC II (green) expressing cells adjacent to large CD200+ (red) endothelial cells. (G) MHC II
(green) expressing cells adjacent to CD31+ (red) endothelial cells. Sections were counterstained with TOTO-3 (blue) to detect DNA. Magnification = 63x,
white scale bars = 20μm.
doi:10.1371/journal.ppat.1004641.g005
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our model (48 days pi,S2A Fig.). Thus, CD200R restricted mucosal myeloid cell accumulation
during early time-points of SG infection rather than influencing myeloid cell turnover during
the resolution phase of infection.
Tissue resident macrophages proliferate in response to inflammatory stimuli [39, 40]. Thus,
we measured SG-APC proliferation before and after MCMV infection 7 days pi. Low levels of
SG-APC homeostatic proliferation were measured in naïve wt and CD200R-/- mice (Fig. 5D).
However, infection-induced SG-APC proliferation was further elevated in CD200R-/- mice as
compared to wt mice day 7 pi (Fig. 5D&E), a time at which CD200R was expressed by these
cells in wt mice (Fig. 1D&E). This suggested that increased SG-APC accumulation in
CD200R-/- mice was a consequence of heightened proliferation. Importantly, visualization of
MHC II+ cells within the SGs revealed that MHC II+ cells were consistently located adjacent to
large CD200+ cells 7 days (Fig. 5F) and 14 days (S2B Fig.) pi. In accordance with CD200 ex-
pression by CD31+ cells (Fig. 2A), MHC II+ cells were also observed surrounding CD31+ ves-
sels (Fig. 5G), suggesting that tissue-resident MHC II+ SG-APC interactions with CD200-
bearing endothelial cells restricts infection-induced cellular proliferation. In support of this
conclusion, chimeric mice lacking CD200 only in non-hematopoietic cells exhibited increased
SG-APC accumulation (S2C Fig.). Furthermore, improved control of MCMV in these mice
(Fig. 4) in addition to the absence of an impact of non-hematopoietic cell-derived CD200 on
splenic DC responses (S2D Fig.) points towards a role for local SG-APC expansion in deter-
mining control of MCMV replication in the mucosa.
CD4 T cells limit virus persistence in CD200R-/- mice
CD4 T cells are critical effector cells in the control of MCMV persistence that afford protection
via expression of IFNγ [38, 41]. Despite the absence of measurable T cell expression of
CD200R (Fig. 1D), SG-infiltrating CD4 T cells in CD200R-/- mice exhibited increased activa-
tion, indicated by CD69 and CD25 up-regulation 10 days pi (Fig. 6A&B). Enrichment of
CD25hi CD4 T cells were not observed in either wt or CD200R-/- mice (Fig. 6A), consistent
with the absence of regulatory T cell infiltration into the SGs in response to MCMV [31]. Im-
portantly, IFNγ+ virus-specific CD4 T cell numbers were elevated in the SGs of CD200R-/-
mice by 14 days pi (Fig. 6C). In addition to activated T cells, CD4+ tissue-resident memory T
cells also express CD69 [42]. Interestingly, whereas CD69 expression by SG CD4 T cells was el-
evated in CD200R-/- mice 14 (Fig. 6D) and 30 (S3A Fig.) days pi, elevated prolonged expression
of CD25 by CD200R-/- SG CD4 T cells was not observed (S3B Fig.), implying that CD200R
may also restrict the accumulation and/or retention of CD4 T cells with a tissue-resident mem-
ory-like phenotype. Furthermore, MHC II+ SG-APCs that proliferate and accumulate to higher
numbers in CD200R-/- mice (Fig. 5B–E) co-localized with CD4 T cells (Fig. 6E), suggesting
that elevated myeloid cell responses within the SGs of CD200R-/- mice enhanced mucosal CD4
T cell responses. In addition, elevated splenic DC numbers 14 days pi in CD200R-/- mice
(Fig. 5A) were accompanied by an increase in virus-specific CD4 T cells in this organ at this
time (Fig. 6F). These data therefore suggested that CD200R restricted peripheral and mucosal
CD4 T cell responsiveness during virus persistence through localized regulation of tissue
APC accumulation.
We next investigated whether elevated CD4 T cell responses restricted MCMV persistence
in CD200R-/- mice. Depletion of CD4 T cells abrogated the improved control of MCMV in
CD200R-/- mice (Fig. 6G), which is consistent both with the established role for CD4 T cells in
limiting MCMV persistence in the SGs [38, 41], and the conclusion that MCMV exploits
CD200R to facilitate persistence predominantly by antagonizing proliferation and accumula-
tion of MHC class II-bearing myeloid cells.
CD200R Restricts Myeloid Cell Orchestration of Anti-CMV Immunity
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Discussion
We demonstrate that MCMV exploits the CD200-CD200R pathway to restrict mucosal antivi-
ral immunity in vivo to facilitate MCMV persistence in a secretory mucosal organ. Restriction
of myeloid cell responses was central to the inhibitory action of CD200R. CD200R signaling
limited accumulation of MHC class II-bearing APCs in both the periphery and mucosa thus re-
stricting the ensuing virus-specific CD4 T cell response. CD200R restricted SG-APC responses
by limiting virus-induced cellular proliferation. CD200R inhibition of this process has likely
evolved to limit responses to harmless antigens that mucosal surfaces are continually exposed
to. However our data demonstrate that MCMV benefits from this immune-regulatory pathway
to persist within its mammalian host, and MCMV can actively induce CD200 expression
during infection.
SG-APCs proliferated in response to MCMV infection, consistent with the ability of tissue-
resident macrophages to undergo a proliferative burst following inflammation [39, 40, 43].
Our data suggest that the interaction of SG-APCs with the basal surface of CD200-bearing
Figure 6. CD4 T cells limit virus persistence in CD200R-/- mice. (A-B) CD69 and CD25 expression by SG CD4 T cells was assessed 10 days pi by flow
cytometry and data depicted as histogram overlays (A) and percent expression by individual mice + mean (B). FMO in (A) was derived from d10 infected
CD200R-/- mice. (C) MCMV-specific SG CD4 T cells were isolated 14 days pi, stimulated with pooled MCMV-derived peptides (m09, M25, M139 and m142)
and peptide-reactive IFNγ+ cells were enumerated by flow cytometry. Results represent the mean and SEM of 4–6 mice/group, representing 2 experiments.
(D) CD69 expression by CD4 T cells from the SGs and spleen at 14 days pi was determined by flow cytometry. Percent CD69 expression of individual mice +
mean is shown. (E) Co-localization of MHC class-II expressing cells (green) with CD4 T cells (red) in the SGs 7 days pi. White arrows indicate co-localization
of CD4 T cells with MHC II+ cells. Magnification = 63x, scale bars = 20μm. (F) Virus-specific CD4 T cells were enumerated in the spleen over a time-course as
described in (C). Results represent the mean and SEM of 4–6 mice/group, representing 2 experiments. (G) Wt and CD200R-/- mice were infected with MCMV
and treated with αCD4 depleting antibodies or PBS control at days 4 and 6 pi. SGs were harvested 14 days pi and virus load assessed by plaque assay.
Horizontal dashed line depicts the lower limit of detection. Individual mice and median are shown and data is representative of 2 experiments.
doi:10.1371/journal.ppat.1004641.g006
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endothelial cells limits this process, and implies that the large vascular network within the SGs
may function not only as a blood supply but also to deliver inhibitory signals that, in the con-
text of homeostatic conditions, functions to limit immune responsiveness. The identification of
ring-like structures surrounding acini implies a scenario during MCMV infection in which
CD200R-expressing myeloid cells situated close to or migrating towards infected cells may re-
ceive inhibitory signals from CD200-expressing vascular structures.
Currently, there are no methodologies available to exclusively delete SG-APCs in vivo.
Therefore we are unable to make definitive conclusions regarding the function of these cells in
our experiments. However, our data supports a model in which CD200R-mediated restriction
of SG-APC proliferation reduces CD4 T cell activation within the SGs, subsequently impairing
CD4 T cell responsiveness and control of MCMV persistence. Our data also demonstrated that
CD200R impaired the accumulation of virus-specific CD4 T cells in the periphery that was ac-
companied by reduced splenic DC accumulation. Thus, CD200R signaling impinges on antivi-
ral protection from mucosal MCMV replication by restricting CD4 T cell activation and
expansion both within the mucosa itself, but also in secondary lymphoid tissue.
Intriguingly, persistent MCMV infection of CD200R-/- mice led to the enrichment of
CD69+ CD4 T cells not expressing the activation marker CD25. CD69 is expressed by tissue-
resident memory CD4 T cells [42]. MCMV replication continued at the time-points at which
CD69+ CD4 T cells were detected in our study, thus precluding definitive conclusions regard-
ing bone fide tissue-resident memory cells. However, our data implies that CD200R may indi-
rectly restrict the accumulation of CD4 T cells in the SGs that exhibit a phenotype indicative of
tissue-resident memory CD4 T cells.
CD200R facilitates early viral replication in acute MHV [12] and HSV [13] infections in
vivo. In contrast, we observed that early control of MCMV was unaffected by CD200R. This
may reflect in part that CD200R deficiency did not influence MCMV replication in macro-
phages (S4A Fig.), unlike data reported in HSV infection [13]. Improved control of MHV in-
fection in CD200-/- mice was associated with elevated type I IFN [12]. Type I IFN was not
measured in our study and may not be altered in MCMV-infected CD200R-/- mice. Also, type I
IFN exerts potent antiviral activity against MCMV in vivo in wt mice [44] and may therefore
be produced at levels that exert maximal antiviral activity in our model irrespective of any im-
pact of CD200R on cytokine expression.
Instead, we show for the first time that CD200R signaling influences persistent virus replica-
tion in vivo. Improved control of MCMV replication in the SGs in CD200R-/-mice was intrigu-
ing given that MCMV does not encode an obvious CD200 homolog. This may be explained in
part by the existence of a structural CD200 ortholog encoded by MCMV that lacks sufficient
sequence similarity to be detected, or by the existence of other viral ligands for CD200R. Im-
portantly however, experiments utilizing CD200-/- mice highlighted a role for cellular CD200
in dampening antiviral immunity. Cellular CD200 restricts virus-induced immune responses
in acute virus infections [8, 12, 45], and our data supports the conclusion that some viruses
may exploit host CD200-CD200R interactions to establish persistence. Intriguingly, in vivo ex-
periments investigating a functional role for CD200 orthologs expressed by RCMV [26] and
Rhesus macaque rhadinovirus [46] failed to detect significant benefit of these vCD200s in pro-
moting herpesvirus persistence in these experimental models. Our data suggest the benefit of
herpesvirus exploitation of host CD200 expression, irrespective of whether the virus also en-
codes its own vCD200 protein.
Results obtained from bone marrow chimeras demonstrate the importance of non-hemato-
poietic cell-derived CD200 in facilitating MCMV persistence, thus supporting an important
role for endothelial cells in indirectly restricting antiviral CD4 T cell responses via regulation of
myeloid cells. However, a significant role for hematopoietic cells in promoting virus persistence
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was also revealed in these experiments. Peripheral and mucosal myeloid cells expressed CD200
during MCMV infection. Although SG-APCs did not support MCMV replication, splenic
macrophages up-regulated CD200 following direct MCMV infection in vitro. MCMV infection
of wt and CD200R-/- bone marrow-derived macrophages resulted in comparable expression of
MHC II (S4B Fig.), suggesting that MCMV does not exploit macrophage expression of CD200
to deliver an autocrine inhibitory signal; a conclusion further supported by comparable
MCMV replication in wt and CD200R-/- macrophages and consistent with the inability of
CD200 to interact with CD200R in a cis-cellular fashion [47, 48].
Instead our data suggest that a CD200-bearing myeloid cell may restrict antiviral immunity
and that, in the case of peripheral infection, MCMV influences this process.
CD200 may suppress myeloid cell activity and/or accumulation indirectly via an unknown
CD200R-expressing cell subset, or by directly triggering CD200R signaling within a myeloid
cell. T cells expressed CD200 during MCMV infection, implying that MCMVmay also passive-
ly exploit a negative feedback loop by which CD200-bearing T cells deliver an inhibitory signal
to CD200R-bearing myeloid cell with which they interact. Notably however, non-hematopoiet-
ic cell-derived CD200 restricted myeloid cell accumulation within the SGs, suggesting that T
cells do not exert CD200-mediated inhibition of myeloid cell proliferation within this particu-
lar site of MCMV infection. Irrespective of the exact mechanism(s), our data suggest that
CD200 expressed by hematopoietic cells impacts on the development of antiviral immunity
that subsequently allows virus persistence within the SGs, and that MCMV actively exploits
this process.
MCMV induced myeloid cell CD200 expression via two distinct mechanisms. Firstly, in-
complete virus replication triggered TLR-induced IFNβ-dependent Cd200 gene expression.
Importantly, replication-competent virus induced Cd200 expression in macrophages indepen-
dently of this pathway, and CD200 induction was dependent upon viral DNA polymerase ac-
tivity. The mechanism through which MCMV actively regulates CD200 is not clear. CMV
infection induces profound alterations in host cell protein production and gene expression
[49–52]. Concurrent analysis of Cd200 gene and surface protein expression highlighted that
viral induction of CD200 occurred at the transcriptional level. The impact of PAA on virus-
induced CD200 expression suggests the involvement of a gene product or products expressed
during the latter stages of virus replication. However, this conclusion is guarded given that in-
hibition of viral DNA polymerase during HCMV infection also incompletely inhibits produc-
tion of certain viral proteins expressed at early times during the virus life-cycle [53].
Whether a viral gene product(s) directly or indirectly induces CD200 expression and which
viral protein is responsible remains to be elucidated. Influenza infection of macrophages did
not trigger CD200 expression despite the CD200-CD200R pathway restricting influenza-
induced T cell responses in vivo [8, 12]. Thus, CD200 induction is not a generic response
mounted by macrophages in response to viruses. Instead, our experiments demonstrate that
MCMV gene expression is essential for this process and implies that CD200 up-regulation rep-
resents a previously unappreciated mechanism exploited by CMV, and perhaps other viruses,
to antagonize host antiviral immunity.
Collectively, our study highlights a central role for myeloid cells in modulating cytomegalo-
virus-specific T cell responses in mucosal tissue and the potential importance of regulation of
tissue-resident macrophage proliferation in this process. Our study also points towards the ma-
nipulation of cellular CD200 expression as a mechanism through which herpesviruses evade
host immunity, suggesting that MCMV exploits CD200R signaling to antagonize myeloid cell
orchestration of antiviral immunity to promote persistence within and dissemination from
the mucosa.
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Materials and Methods
Mice, viral infections and treatments
C57BL/6 experimental mice were obtained from Harlan UK. CD200R-/- mice were originally
generated and provided by Reginald Gorczynski (University Health Network, Toronto), and
David Copland (University of Bristol) provided the OX-2-/- mice, with kind permission from
Jonathon Sedgwick (Eli Lilly, Indianapolis). IL-10-/- mice were purchased from Jackson Labo-
ratories and maintained in-house.
MCMV Smith strain (ATCC) was prepared in BALB/c salivary glands and purified over a
sorbital gradient. Mice were infected by the intra-peritoneal route (i.p) with 3 x 104 PFU
MCMV. Some mice were injected i.p with 200µg αCD4 antibody (100µg clone YTS191, 100µg
clone YTS3) on days 4 and 6 pi. To measure proliferation in vivo, mice were injected i.p with
1mg/mouse EdU (Life Technologies) at day 6 pi. To generate chimeric mice, recipients were ir-
radiated at 2 x 550G, transfused intra-venous (i.v) with 1 x 106 bone marrow cells 24 hours
later. Mice were then treated for 3 weeks with baytril-supplemented water. Mice were infected
with MCMV 8 weeks after irradiation.
Ethics statement
All experiments were conducted according to the UK Home Office guidelines at the designated
facility at Heath Park, Cardiff University under UK Home Office-approved project licenses
PPLs 30/2442 and 30/2969.
Leukocyte isolation and flow cytometry
SGs and spleens were surgically excised frommice that were euthanized with carbon dioxide. SGs
were cut into small pieces and incubated in RPMI 1640 medium (Invitrogen) supplemented with
5 mMCaCl2, 5% FCS (Invitrogen), 1 mg/ml collagenase D (Roche Diagnostics), and 10 mg/ml
DNAse I (Sigma) at 37°C for 45 minutes, before passing through a cell strainer prior to red blood
cell lysis. Leukocytes were then stained with Live/Dead (Invitrogen) prior to incubation with Fc
block (eBioscience). Lymphocytes were then stained with a combination of αCD3e-PerCP (Clone
145.2C11, Biolegend), αF4/80-Pacific-Blue (Clone BM8; Biolegend), αIA/IE-PerCP-Cy5.5 (Clone
M5/114.15.2, BioLegend), αCD11c-PeCy7 (Clone N418, Biolegend), αNK1.1-allophycocyanin
(Clone PK136, BD Biosciences), αCD4-Pacific-blue (Clone RM4.5, BD Biosciences), αCD25-
APC-Cy7 (Clone PC61, Biolegend) and αCD69-FITC (Clone H1.2F3, eBioscience).
To detect EdU incorporation, cells were stained as above, fixed with 4% PFA, permeabilized
with Saponin buffer, and EdU was labeled with Alexa Fluor 647 using the Click-iT Plus EdU
Alexa Fluor 647 Flow Cytometry Assay Kit (Life Technologies) as per manufacturer’s protocol.
To detect MCMV-specific CD4 T cells, leukocytes were incubated with 3μg MCMV peptides
(Genscript) listed in Figure legends for 6 hours, with BFA (Sigma) for the final 4 hours. CD4 T
cells stained as above were permeabilized prior to staining with αIFNγ FITC (clone XMG1.2,
eBioscience).
All data were acquired on a BD FACS Canto II. Electronic compensation was performed
with antibody-capture beads (BD Biosciences). Data was analyzed using FlowJo software ver-
sion 10.0.3 (TreeStar Inc, Ashland, OR). Total numbers of different cell populations were cal-
culated by multiplying % positive viable cells detected by flow cytometry x the total number of
viable leukocytes (assessed by trypan blue exclusion).
In vitromacrophage infections
Femurs were surgically excised from wt and CD200R-/- mice, sterilized in 70% ethanol and
washed in PBS. Bone marrow was isolated, cells centrifuged, washed in RPMI and passed
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through a 40µM cell strainer. Cells were incubated at 2 x 105 cells/well in D10 media supple-
mented with 20ng/ml of M-CSF (Peprotech) for 7 days, replenishing M-CSF after 3 days.
Spleens and SGs were processed as previously described, with an additional Percoll (GE
Healthcare) purification step for SGs after processing. Bone-marrow derived macrophages
were infected with MCMV or influenza (PR8) at an MOI of 1. Some cells were also incubated
with 300μg/ml phosphonoacetic acid (PAA, Sigma-Aldrich) for 1 hour prior to infection. Sple-
nocytes (2 x 105 cells/well) and SG leukocytes (2 x 104 cells/well) were infected in 48-well plates
and infected with MOI 0.5 MCMV. After 24hrs, all macrophages were gently scraped gently off
the bottom of the wells, stained with Live/Dead1 fixable aqua dead cell stain (Invitrogen) and
Fc block (eBioscience), and surface stained with αCD200-PE (Clone OX-90, Biolegend),
αCD80 Pacific blue (Clone 16–10A1, Biolegend), αCD86 FITC (Clone GL-1, BD Pharmingen),
and αIA/IE PerCP/Cy5.5 (Clone M5/114.15.2, Biolegend) prior to permeabilization and stain-
ing with anti-m06 antibody (a kind gift from Stipan Jonjic, Rijeka) conjugated with APC
(Innova Biosciences).
Immunofluorescence
SGs were frozen in OCT and 5μm thick sections fixed in acetone. Sections were blocked with
Avidin/Biotin Blocking Kit (Vectorlabs) and then with 2.5% Normal Horse Serum (Vector-
labs). Sections were incubated overnight at 4°C in the dark with CD31-Biotin (Clone MEC
13.3, BD Pharmingen) or CD200-Biotin (Clone OX-90, BioLegend), and MHC II-FITC (Clone
M5/114.15.2, BioLegend) or EpCAM (Clone E144, AbCam). Alexa Fluor 488 anti-rabbit IgG
(Invitrogen) and Streptavidin Alexa Fluor 555 conjugate (Invitrogen) were used as secondary
stains for EpCAM, and CD200-Biotin and CD31-Biotin, respectively. Sections were counter-
stained with TOTO-3 (Invitrogen), then fixed with 1% PFA and treated with 0.3M glycine. To
investigate CD200 colocalization with CD31 or CD45, and MHC II colocalization with CD4,
sections were incubated with CD45 (Clone 30-F11, Biolegend), CD31-FITC (Clone 390,
eBioscience) or CD4 (Clone RM4–5, Biolegend) overnight at 4°C in the dark. Alexa Fluor 488
anti-rat IgG (Life Technologies), FITC anti-rat IgG2b antibody (Biolegend) and Alexa Fluor
568 goat anti-rat (Life Technologies) were used as secondary stains for CD31-FITC, CD45 and
CD4, respectively. Sections were fixed in 1% PFA and treated with 0.3M glycine and then incu-
bated with anti-CD200-Biotin for 2 hours at room temperature, followed by Streptavidin Alexa
Fluor 555 conjugate (Invitrogen), or MHC II-FITC (without secondary antibody). Sections
were counterstained with TOTO-3 (Invitrogen) and fixed. The following isotype controls were
used: Rat IgG2a-Biotin (BD Pharmingen) for CD200-Biotin and CD31-Biotin, Rat IgG2a-
FITC (eBioscience) for CD31-FITC, Rat IgG2b-FITC (eBioscience) for MHC II-FITC, Rabbit
IgG (AbCam) for EpCam, Rat IgG2a (eBioscience) for CD4, and Rat IgG2b (BD Pharmingen)
for CD45. Images were collected with a Zeiss Axioskop 2 FS mot confocal microscope. Images
were assembled using ImageJ software.
Gene array analysis of CD200 mRNA expression
Wt and IFNβ1-/- bone marrow derived macrophages (BM-DM) were derived from C57/BL6
mice as previously described [54] and grown in 24 well plates. After 7 days of culture, BM-DM
were infected with wt-MCMV, MCMVΔIE3 (MOI = 1) or mock infected [55]. Cells were then
harvested at 2, 4, 6, 8, 10 and 24 hours post-infection for the isolation of RNA using an RNeasy
Mini kit (Qiagen, UK) according to manufacturer’s instructions. After QC using an Agilent
Bioanalyzer, total RNA was labeled and hybridized to Mouse Gene 1.0ST microarrays (Affyme-
trix, CA, USA) according to manufacturer’s instructions using a WT Expression kit (Ambion,
UK). After data capture, quality control metrics were assessed using Affymetrix Expression
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Console software and then all arrays were imported into Partek Genomics Suite (Partek, USA)
for downstream analysis. In brief, arrays were normalized using the gcRMA algorithm [56].
After normalization, to increase confidence in the genes taken forward to statistical analysis,
data was filtered to include genes with at least 1 signal value of> = 150 across the time course.
Statistics
For viral load analysis, statistical significance was determined using the Mann-Whitney U test
for paired groups. To analyze viral load data from bone marrow chimeras, linear regression
analysis was utilized. Data were first subject to square-root transformation to introduce
stability. We then fitted a linear model for covariates (donor + recipient) with and without the
interaction term. Subsequent ANOVA analysis of these models showed the interaction term
not to be significant (p = 0.13). However a model without any interactions is strongly signifi-
cant (p = 0.0015) and was therefore used. For paired analysis of flow cytometry data, the
two-tailed Student’s t test was utilized. For bone marrow chimeras, linear regression of non-
transformed data was used. p<0.05, p<0.01, p<0.001.
Gene accession numbers
mCD200–17470; mCD200R- 57781l; IFNγ- 15978; mIL-10–16153; mCD69–12515; mCD31/
PECAM-1–18613; mIFNB1–15977; mCD80–12519
Supporting Information
S1 Fig. CD200 is expressed by endothelial cells not myoepithelial cells. (A) Isotype controls.
Day 7 pi SG sections were stained with: (Left) CD200 (red) and Rat IgG2a-FITC (green), and
the secondary antibodies Streptavidin 555 and Alexa Fluor 488 anti-rat IgG; (Right) CD31-
FITC (green) and Rat IgG2a-Biotin (red), and the secondary antibodies Streptavidin 555 and
Alexa Fluor 488 anti-rat IgG. (B) Myoepithelial cells (detected by alpha-smooth muscle actin
(green)) do not express CD200 (red) in the SGs at day 14 pi. Rabbit IgG and Rat IgG2a-Biotin
isotype controls were used. Magnification = 63x, white scale bars = 20μm. (C) CD200 (red) and
CD31-FITC (green) co-staining of endothelial cells on a wt naïve SG section show colocaliza-
tion of CD200 and endothelial cells. All sections were counterstained with TOTO-3 (blue) to
detect DNA. Magnification = 63x, white scale bars = 20μm.
(TIFF)
S2 Fig. Endothelial cells express CD200 during MCMV persistence and restrict SG-APC ac-
cumulation. (A) SG-APCs in wt and CD200R-/- mice were enumerated 48 days post MCMV
infection. (B) Wt mice were infected with MCMV and SGs harvested 14 days pi. MHC II
(green) expressing cells adjacent to large CD200+ (red) endothelial cells are shown. Sections
were counterstained with TOTO-3 (blue) to detect DNA. Magnification = 63x, white scale
bars = 20μm. (C&D) Mixed wt/CD200-/- bone marrow chimeras were generated and infected
with MCMV. After 14 days, SG-APCs (C) and splenic DCs (D) were quantified. Individual
mice + mean are shown.
(TIFF)
S3 Fig. CD69+ CD4 T cells are enriched in CD200R-/- mice during MCMV persistence.Wt
and CD200R-/- mice were infected with MCMV, and CD69 (A) and CD25 (B) expression by
CD4 T cells from the SGs (A&B) and spleen (A) was determined 30 days pi. % expression of in-
dividual mice + mean is shown.
(TIFF)
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S4 Fig. CD200R does not influence MCMV replication in macrophages, or MHC II expres-
sion by macrophages. (A) Wt and CD200R-/- BM-DMs were infected with MCMV (MOI: 0.5)
and MCMV in supernatants were quantified by plaque assay after 6 days. Median + range is
shown. (B) Representative plots from 2 experiments of F4/80 and MHC class II expression by
wt (top) and CD200R-/- (bottom) BM-DMs 24 hours after MCMV infection.
(TIFF)
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